...
首页> 外文期刊>The European journal of health economics: HEPAC : health economics in prevention and care >Lead me not into temptation: Drug price regulation and dispensing physicians in Switzerland
【24h】

Lead me not into temptation: Drug price regulation and dispensing physicians in Switzerland

机译:引导我不要陷入诱惑:瑞士的药品价格监管和配药医师

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

While most countries separate drug prescription and dispensation to ensure independent drug choice, some allow this combination to increase pharmaceutical access in rural areas or to increase the utilization of pharmacist skills. A drawback of this approach is that dispensing physicians or prescribing pharmacists may be incentivized to increase their own profits through the prescription of cost-inefficient drug packages, leading to an increase in pharmaceutical spending. Switzerland constitutes an interesting example of where dispensing and non-dispensing physicians coexist, permitting a comparison of their prescribing behavior. The present study shows that drug margin optimization is possible under the current drug price regulation scheme in Switzerland. Using drug claims data, empirical findings indicate a 5-10 % higher margin per dose for dispensing physicians compared to pharmacists. Cost per dose is 3-5 % higher when dispensed by physicians instead of pharmacists.
机译:虽然大多数国家将药物处方和配药分开以确保独立选择药物,但有些国家允许这种组合增加农村地区的药物获取或提高药剂师技能的利用率。这种方法的缺点是,通过降低成本的低效药物包装的处方,可能会激励配药医师或开药师增加自己的利润,从而导致药品支出的增加。瑞士是一个有趣的例子,在这里,配药医师和非配药医师共存,可以比较他们的处方行为。本研究表明,根据瑞士现行的药品价格监管计划,可以优化药品利润率。使用药物声明数据,经验发现表明,与药剂师相比,配药医师每剂量的利润高出5-10%。当由医生而不是药剂师分配时,每剂量的成本要高出3-5%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号